Published in PLoS One on August 19, 2014
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans. Matrix Biol (2015) 1.91
Role of tyrosine-sulfated proteins in retinal structure and function. Exp Eye Res (2015) 0.75
Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10
Complement factor H variant increases the risk of age-related macular degeneration. Science (2005) 17.95
Complement factor H polymorphism and age-related macular degeneration. Science (2005) 17.79
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A (2005) 13.44
RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol (1996) 9.77
Regulation of protein export from the endoplasmic reticulum. Annu Rev Cell Biol (1988) 4.53
The biology and enzymology of protein tyrosine O-sulfation. J Biol Chem (2003) 2.80
Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J Biol Chem (1987) 2.62
The Sulfinator: predicting tyrosine sulfation sites in protein sequences. Bioinformatics (2002) 2.51
Tyrosine sulfation is a trans-Golgi-specific protein modification. J Cell Biol (1987) 2.10
Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. J Proteome Res (2006) 2.04
Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J (1999) 2.00
Tyrosine replacement in P-selectin glycoprotein ligand-1 affects distinct kinetic and mechanical properties of bonds with P- and L-selectin. Proc Natl Acad Sci U S A (1999) 1.93
A new map of glycosaminoglycan and C3b binding sites on factor H. J Immunol (2008) 1.89
Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet (1999) 1.88
A family with Stickler syndrome type 2 has a mutation in the COL11A1 gene resulting in the substitution of glycine 97 by valine in alpha 1 (XI) collagen. Hum Mol Genet (1996) 1.81
Complement biosynthesis by the human hepatoma-derived cell line HepG2. J Clin Invest (1982) 1.75
A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin. J Cell Biol (1993) 1.74
Determination and occurrence of tyrosine O-sulfate in proteins. Methods Enzymol (1984) 1.68
Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO J (2002) 1.64
Tyrosine sulfation and the secretory pathway. Annu Rev Physiol (1988) 1.60
Tyrosine sulfation: an increasingly recognised post-translational modification of secreted proteins. N Biotechnol (2009) 1.45
Interphotoreceptor retinoid-binding protein (IRBP). Molecular biology and physiological role in the visual cycle of rhodopsin. Mol Neurobiol (1993) 1.41
Complement in age-related macular degeneration: a focus on function. Eye (Lond) (2011) 1.39
Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. Exp Eye Res (2006) 1.36
Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein. Acta Pathol Microbiol Immunol Scand Suppl (1984) 1.32
Basal laminar drusen caused by compound heterozygous variants in the CFH gene. Am J Hum Genet (2008) 1.27
Reduced body weight and increased postimplantation fetal death in tyrosylprotein sulfotransferase-1-deficient mice. J Biol Chem (2002) 1.20
Detection and purification of tyrosine-sulfated proteins using a novel anti-sulfotyrosine monoclonal antibody. J Biol Chem (2006) 1.19
Early postnatal pulmonary failure and primary hypothyroidism in mice with combined TPST-1 and TPST-2 deficiency. Gen Comp Endocrinol (2007) 1.16
Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations. J Biol Chem (2009) 1.15
Targeted disruption of tyrosylprotein sulfotransferase-2, an enzyme that catalyzes post-translational protein tyrosine O-sulfation, causes male infertility. J Biol Chem (2006) 1.15
Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities. J Biol Chem (2011) 1.15
The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties. J Mol Biol (2007) 1.14
Immunolocalisation of opticin in the human eye. Br J Ophthalmol (2004) 1.12
Identification of tyrosine sulfation in extracellular leucine-rich repeat proteins using mass spectrometry. J Biol Chem (2003) 1.12
Tyrosine sulfation enhances but is not required for PSGL-1 rolling adhesion on P-selectin. Biophys J (2001) 1.08
Lack of protein-tyrosine sulfation disrupts photoreceptor outer segment morphogenesis, retinal function and retinal anatomy. Eur J Neurosci (2010) 1.08
Human complement factor H: expression of an additional truncated gene product of 43 kDa in human liver. Eur J Immunol (1987) 1.06
Chapter 7. Tyrosine sulfation of HIV-1 coreceptors and other chemokine receptors. Methods Enzymol (2009) 1.05
Sub-lytic C5b-9 induces functional changes in retinal pigment epithelial cells consistent with age-related macular degeneration. Eye (Lond) (2011) 1.04
Complement dysregulation in AMD: RPE-Bruch's membrane-choroid. Mol Aspects Med (2012) 1.03
Determination of the sites of tyrosine O-sulfation in peptides and proteins. Nat Methods (2007) 1.03
Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. PLoS Pathog (2010) 1.02
Associative and structural properties of the region of complement factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin. J Mol Biol (2007) 1.00
Site-specific N-glycan characterization of human complement factor H. Glycobiology (2007) 0.97
Protein tyrosine-O-sulfation in bovine ocular tissues. Adv Exp Med Biol (2012) 0.95
The Wnt antagonist, Dickkopf-1, as a target for the treatment of neurodegenerative disorders. Neurochem Res (2008) 0.94
Opticin binds retinal growth hormone in the embryonic vitreous. Invest Ophthalmol Vis Sci (2003) 0.94
Characterization of opticin and evidence of stable dimerization in solution. J Biol Chem (2003) 0.93
Recombinant human fibrinogen and sulfation of the gamma' chain. Biochemistry (1991) 0.93
Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d. Mol Immunol (2010) 0.93
Tyrosine sulfation influences the chemokine binding selectivity of peptides derived from chemokine receptor CCR3. Biochemistry (2011) 0.92
Increased vitronectin production by complement-stimulated human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2009) 0.92
Identification of the site of sulfation of the fourth component of human complement. J Biol Chem (1986) 0.91
Modifications of glycans: biological significance and therapeutic opportunities. ACS Chem Biol (2012) 0.90
Tyrosylprotein sulfotransferase-2 expression is required for sulfation of RNase 9 and Mfge8 in vivo. J Biol Chem (2008) 0.90
Vitronectin in bronchoalveolar lavage fluid is increased in patients with interstitial lung disease. Am Rev Respir Dis (1991) 0.90
Identification of opticin, a member of the small leucine-rich repeat proteoglycan family, in human articular tissues: a novel target for MMP-13 in osteoarthritis. Osteoarthritis Cartilage (2008) 0.88
Identification of two sites of sulfation of human heparin cofactor II. J Biol Chem (1986) 0.88
Serine/threonine kinase akt activation regulates the activity of retinal serine/threonine phosphatases, PHLPP and PHLPPL. J Neurochem (2010) 0.87
The location of tyrosine-O-sulphate in fibrinopeptides. Acta Chem Scand (1968) 0.87
Interaction of complement factor h and fibulin3 in age-related macular degeneration. PLoS One (2013) 0.86
The vitreous glycoprotein opticin inhibits preretinal neovascularization. Invest Ophthalmol Vis Sci (2012) 0.86
Sulfation of two tyrosine-residues in human complement S-protein (vitronectin). Eur J Biochem (1989) 0.85
Reevaluation of the determinants of tyrosine sulfation. Endocrine (1999) 0.83
Site-specific inhibition of integrin alpha v beta 3-vitronectin association by a ser-asp-val sequence through an Arg-Gly-Asp-binding site of the integrin. Proteomics (2010) 0.83
Differential developmental deficits in retinal function in the absence of either protein tyrosine sulfotransferase-1 or -2. PLoS One (2012) 0.83
Opticin exerts its anti-angiogenic activity by regulating extracellular matrix adhesiveness. J Biol Chem (2012) 0.83
Tissue vitronectin in normal adult human dermis is non-covalently bound to elastic tissue. J Invest Dermatol (1991) 0.82
Purification of yolk protein 2 of Drosophila melanogaster and identification of its site of tyrosine sulfation. J Biol Chem (1988) 0.82
Protein tyrosine-O-sulfation in the retina. Exp Eye Res (2009) 0.81
The case for complement and inflammation in AMD: open questions. Adv Exp Med Biol (2010) 0.80
Fibulin 2, a tyrosine O-sulfated protein, is up-regulated following retinal detachment. J Biol Chem (2014) 0.80
Tyrosine O-sulfation of the fibrinogen gamma B chain in primary cultures of rat hepatocytes. J Biol Chem (1988) 0.80
Unravelling protein-protein interactions between complement factor H and C-reactive protein using a multidisciplinary strategy. Biochem Soc Trans (2010) 0.79
Evidence showing that the two-chain form of vitronectin is produced in the liver by a selective furin cleavage. FEBS Lett (2000) 0.78
Tyrosine sulfation in N-terminal domain of human C5a receptor is necessary for binding of chemotaxis inhibitory protein of Staphylococcus aureus. Acta Pharmacol Sin (2011) 0.78
[The Bruch membrane and choroid. Angiography and functional characteristics in age-related changes]. Ophthalmologe (1992) 0.77
Effect of tunicamycin on the synthesis, processing, and secretion of pro-opiomelanocortin peptides in mouse pituitary cells. J Biol Chem (1982) 0.77
Fibrinogen and the fibrinogenopathies. Ann Clin Lab Sci (1973) 0.76
Opticin production is reduced by hypoxia and VEGF in human retinal pigment epithelium via MMP-2 activation. Cytokine (2012) 0.76
Initiation of rod outer segment disc formation requires RDS. PLoS One (2014) 0.88